Drug class
Diagnostic radiopharmaceutical; hepatobiliary iminodiacetic-acid (IDA) imaging agent
Mechanism of action
When labelled with technetium-99m, mebrofenin is rapidly cleared from the circulation by hepatic uptake and excreted into bile. Its gamma emissions allow visualisation of hepatobiliary transit by scintigraphy or SPECT; it has no pharmacological effect at diagnostic doses.
General use cases
- Hepatobiliary scintigraphy to assess liver uptake, biliary excretion and gallbladder/biliary tract function, according to the radiopharmaceutical product protocol.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
